Literature DB >> 26590086

Significance of twist and iNOS expression in human breast carcinoma.

Santhalakshmi Ranganathan1, Arunkumar Krishnan2, Niranjali Devaraj Sivasithambaram3.   

Abstract

Twist is a basic helix-loop-helix transcription factor family normally expressed during embryonic development and apparently activated in variety of tumours. Overexpression of twist is correlated with uncontrolled cell proliferation, differentiation, invasion and metastasis. Twist expression is associated with oestrogen receptor (ER); however, the molecular mechanism behind involvement of twist in progression of breast cancer is still unclear. Nitric oxide synthases (NOSs) which cause damage to the cellular DNA are also shown to be involved in cancer progression. The present study involves total number of n = 85 breast biopsies, which include 19 non-cancer and 66 cancerous lesions. We analysed twist, iNOS and ER expression pattern in human breast carcinomas by RT-PCR and also analysed twist cellular localisation by immunohistochemical analysis. iNOS expression pattern was correlated with different stages of breast carcinoma. Twist expression was significantly increased in cancer lesions when compared to the non-cancer. The breast cancer lesions positive to ER showed positivity to twist (72%) as well. The higher stages of cancer lesions showed a significant expression of twist localised in cytoplasm of the cancer cells. Collectively these data indicate that up-regulation of twist is correlated with the ER presenting breast cancer, and iNOS expression was positively correlated with tumour-node metastasis (TNM) staging of breast cancer. These findings suggest that expression of twist and iNOS may have a functional role in cancer progression.

Entities:  

Keywords:  Breast cancer; Oestrogen receptor; Twist; iNOS

Mesh:

Substances:

Year:  2015        PMID: 26590086     DOI: 10.1007/s11010-015-2606-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer.

Authors:  H-F Yuen; C-W Chua; Y-P Chan; Y-C Wong; X Wang; K-W Chan
Journal:  Histopathology       Date:  2007-04       Impact factor: 5.087

2.  Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade.

Authors:  W Tschugguel; C Schneeberger; G Unfried; K Czerwenka; W Weninger; M Mildner; D M Gruber; M O Sator; T Waldhör; J C Huber
Journal:  Breast Cancer Res Treat       Date:  1999-07       Impact factor: 4.872

Review 3.  Structure and function of helix-loop-helix proteins.

Authors:  C Murre; G Bain; M A van Dijk; I Engel; B A Furnari; M E Massari; J R Matthews; M W Quong; R R Rivera; M H Stuiver
Journal:  Biochim Biophys Acta       Date:  1994-06-21

Review 4.  Inducible nitric oxide synthase: what difference does it make?

Authors:  C Nathan
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

Review 5.  Role of hormones in mammary cancer initiation and progression.

Authors:  I H Russo; J Russo
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

6.  TWIST is expressed in human gliomas and promotes invasion.

Authors:  Maria C Elias; Kathleen R Tozer; John R Silber; Svetlana Mikheeva; Mei Deng; Richard S Morrison; Thomas C Manning; Daniel L Silbergeld; Carlotta A Glackin; Thomas A Reh; Robert C Rostomily
Journal:  Neoplasia       Date:  2005-09       Impact factor: 5.715

7.  Breast and cervical cancer risk in India: an update.

Authors:  Smita Asthana; Sonia Chauhan; Satyanarayana Labani
Journal:  Indian J Public Health       Date:  2014 Jan-Mar

Review 8.  iNOS-selective inhibitors for cancer prevention: promise and progress.

Authors:  Naveena B Janakiram; Chinthalapally V Rao
Journal:  Future Med Chem       Date:  2012-11       Impact factor: 3.808

9.  Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α.

Authors:  F Vesuna; A Lisok; B Kimble; J Domek; Y Kato; P van der Groep; D Artemov; J Kowalski; H Carraway; P van Diest; V Raman
Journal:  Oncogene       Date:  2011-11-07       Impact factor: 9.867

10.  Nitric oxide synthase activity in human breast cancer.

Authors:  L L Thomsen; D W Miles; L Happerfield; L G Bobrow; R G Knowles; S Moncada
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more
  7 in total

1.  B-cell receptor-associated protein 31 promotes migration and invasion in ovarian cancer cells.

Authors:  Haiyan Liang; Jiqiao Dong; Ziyan Cheng; Qian Li; Dingqing Feng; Bin Ling
Journal:  Exp Ther Med       Date:  2021-06-09       Impact factor: 2.447

Review 2.  The role of TLRs in cervical cancer with HPV infection: a review.

Authors:  Xiao Yang; Yanxiang Cheng; Chunsheng Li
Journal:  Signal Transduct Target Ther       Date:  2017-11-03

3.  Glucocorticoids induce production of reactive oxygen species/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer.

Authors:  Renée L Flaherty; Matthew Owen; Aidan Fagan-Murphy; Haya Intabli; David Healy; Anika Patel; Marcus C Allen; Bhavik A Patel; Melanie S Flint
Journal:  Breast Cancer Res       Date:  2017-03-24       Impact factor: 6.466

4.  Transient external force induces phenotypic reversion of malignant epithelial structures via nitric oxide signaling.

Authors:  Benjamin L Ricca; Gautham Venugopalan; Saori Furuta; Kandice Tanner; Walter A Orellana; Clay D Reber; Douglas G Brownfield; Mina J Bissell; Daniel A Fletcher
Journal:  Elife       Date:  2018-03-21       Impact factor: 8.140

5.  Lithocholic Acid, a Metabolite of the Microbiome, Increases Oxidative Stress in Breast Cancer.

Authors:  Patrik Kovács; Tamás Csonka; Tünde Kovács; Zsanett Sári; Gyula Ujlaki; Adrien Sipos; Zsolt Karányi; Dóra Szeőcs; Csaba Hegedűs; Karen Uray; Laura Jankó; Máté Kiss; Borbála Kiss; Damya Laoui; László Virág; Gábor Méhes; Péter Bai; Edit Mikó
Journal:  Cancers (Basel)       Date:  2019-08-27       Impact factor: 6.639

6.  Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism.

Authors:  Katarína Smolková; Edit Mikó; Tünde Kovács; Alberto Leguina-Ruzzi; Adrienn Sipos; Péter Bai
Journal:  Antioxid Redox Signal       Date:  2020-03-18       Impact factor: 8.401

Review 7.  Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment.

Authors:  Margarita Neganova; Junqi Liu; Yulia Aleksandrova; Sergey Klochkov; Ruitai Fan
Journal:  Cancers (Basel)       Date:  2021-12-01       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.